ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new drug combo against standard for advanced lung cancer
Disease control Recruiting nowThis study is testing whether a new three-drug combination works better than the current standard two-drug treatment for advanced lung cancer. It involves 460 adults with newly diagnosed, advanced non-small cell lung cancer who haven't had prior treatment. The trial directly comp…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for advanced lung cancer patients in combination therapy trial
Disease control Recruiting nowThis study is testing several new drug combinations for people with advanced or metastatic non-small cell lung cancer. Researchers want to find safe doses and see if these combinations can shrink tumors and help patients live longer. The trial will involve 152 participants and in…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for lung cancer patients: trial tests multiple treatment strategies
Disease control Recruiting nowThis study aims to find better treatment combinations for people with non-small cell lung cancer. It will test several new drug combinations against current standard treatments in three different groups of patients: those newly diagnosed with advanced cancer, those whose cancer h…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for advanced lung cancer patients in clinical trial
Disease control Recruiting nowThis study is testing a new drug combination called SHR-A2102 with adebrelimab for people with advanced or metastatic non-small cell lung cancer. Researchers want to find the safest and most effective dose and see how well it controls the cancer. The trial will enroll about 248 a…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC